Rangeley Capital, LLC Roivant Sciences Ltd. Transaction History
Rangeley Capital, LLC
- $93.4 Billion
- Q1 2025
A detailed history of Rangeley Capital, LLC transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Rangeley Capital, LLC holds 140,178 shares of ROIV stock, worth $1.52 Million. This represents 1.51% of its overall portfolio holdings.
Number of Shares
140,178
Previous 239,000
41.35%
Holding current value
$1.52 Million
Previous $2.83 Billion
49.97%
% of portfolio
1.51%
Previous 2.54%
Shares
2 transactions
Others Institutions Holding ROIV
# of Institutions
331Shares Held
496MCall Options Held
3.67MPut Options Held
754K-
Qvt Financial LP New York, NY65.8MShares$715 Million69.8% of portfolio
-
Sb Investment Advisers (Uk) LTD London, X061.9MShares$672 Million5.69% of portfolio
-
Viking Global Investors LP46MShares$500 Million1.55% of portfolio
-
Vanguard Group Inc Valley Forge, PA40.8MShares$443 Million0.01% of portfolio
-
Morgan Stanley New York, NY35.9MShares$391 Million0.03% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $7.66B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...